576 related articles for article (PubMed ID: 25250996)
1. Impetigo: diagnosis and treatment.
Hartman-Adams H; Banvard C; Juckett G
Am Fam Physician; 2014 Aug; 90(4):229-35. PubMed ID: 25250996
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of impetigo.
Cole C; Gazewood J
Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597
[TBL] [Abstract][Full Text] [Related]
3. Impetigo update: new challenges in the era of methicillin resistance.
Geria AN; Schwartz RA
Cutis; 2010 Feb; 85(2):65-70. PubMed ID: 20349679
[TBL] [Abstract][Full Text] [Related]
4. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
5. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
Jacobs MR; Jones RN; Giordano PA
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):55S-65S. PubMed ID: 17292581
[TBL] [Abstract][Full Text] [Related]
6. Ozenoxacin: A Novel Topical Quinolone for Impetigo.
Wren C; Bell E; Eiland LS
Ann Pharmacother; 2018 Dec; 52(12):1233-1237. PubMed ID: 29962213
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, comparative study to assess the safety and efficacy of topical retapamulin ointment 1% versus oral linezolid in the treatment of secondarily infected traumatic lesions and impetigo due to methicillin-resistant Staphylococcus aureus.
Tanus T; Scangarella-Oman NE; Dalessandro M; Li G; Breton JJ; Tomayko JF
Adv Skin Wound Care; 2014 Dec; 27(12):548-59. PubMed ID: 25396674
[TBL] [Abstract][Full Text] [Related]
9. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
[TBL] [Abstract][Full Text] [Related]
10. Impetigo.
Johnson MK
Adv Emerg Nurs J; 2020; 42(4):262-269. PubMed ID: 33105179
[TBL] [Abstract][Full Text] [Related]
11. Common Skin Conditions in Children and Adolescents: Bacterial Infections.
Zha M; Usatine R
FP Essent; 2024 Jun; 541():14-19. PubMed ID: 38896826
[TBL] [Abstract][Full Text] [Related]
12. The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety.
Davino G; D'Alvano T; Esposito S
Front Pharmacol; 2020; 11():559708. PubMed ID: 33364940
[TBL] [Abstract][Full Text] [Related]
13. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
[TBL] [Abstract][Full Text] [Related]
14. Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Schachner LA; Andriessen A; Benjamin LT; Claro C; Eichenfield LF; Esposito SM; Keller L; Kircik L; Kwong PC; McCuaig C
J Drugs Dermatol; 2021 Feb; 20(2):134-142. PubMed ID: 33538559
[TBL] [Abstract][Full Text] [Related]
15. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
[TBL] [Abstract][Full Text] [Related]
16. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%.
Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241
[TBL] [Abstract][Full Text] [Related]
17. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.
Yang LP; Keam SJ
Drugs; 2008; 68(6):855-73. PubMed ID: 18416589
[TBL] [Abstract][Full Text] [Related]
18. Retapamulin: a newer topical antibiotic.
Dhingra D; Parakh A; Ramachandran S
J Postgrad Med; 2013; 59(2):127-30. PubMed ID: 23793314
[TBL] [Abstract][Full Text] [Related]
19. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
[TBL] [Abstract][Full Text] [Related]
20. Ozenoxacin 1% cream (Xepi) for impetigo.
Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
